In August 2025, the FDA also approved Wegovy for the treatment of noncirrhotic MASH with moderate to advanced liver fibrosis 8
Its a popular choice because the muscle is substantial, and the area typically has fewer nerve endings, which can mean less discomfort during the injection
Assistant Professor| Rph | PharmD | Medication Safety | Clinical Research | Pharmacovigilance | Medical Writing Bridging Research, Education & Patient Care Through Evidence-Based Practice Beyond Insulin: Why GLP-1 Therapy is the Future of Metabolic Care Insulin has been the cornerstone of diabetes treatment for nearly a century
Recommended for Sensitive Skin
The central idea is that modern life exposes us to far more environmental stressors than our systems were built for, and that accumulated burden interferes with normal function
References Food and Nutrition Board, Institute of Medicine